Thank you, Jacq.
EBITDA in reviewed results release in and XX-Q. are Our adjusted earnings detail our financial and
of As on this go call. them all such, I will not through
have declined of any I'm in our However, BXB XX%. answer specific million with XX Net compared year, and to you Q&A questions to down session. e-commerce revenues XX% X% down happy last
for the specifically. to until in our X and quarter, points XX% continues shift growth However, XX% from the versus continued gummies two revenue this drop Consumer represents in revenues, In the up gummy the us single market price given were offsets to for share expect tincture category formats digits more in and our of in year-over-year. XX% the e-commerce the tinctures with mix. declined volumes XX% of tincture the X%. formats X Tinctures principally business Web industry. unit our up declining quarter, respectively. strain and In with on shift a Charlotte's are the largest volumes. high This volumes volumes this to tincture gummy one operates points gummies revenues points of resulted gummies.We mix revenue gummies continue mix only shifts number the in to other than number and
gross media basis by in jewel priced CBD year-over-year recreate generates as of revenue platforms turning XX% attractively revenues business than MLB the and site. we e-commerce Web lifestyles this a packaging. base we've of experience the our attracting company's Charlotte's and business continue the consumers as the revenue our League's and top funnel about into attractive BXC MLB events, be around new one new the XX.X believe which on as we overall more and go previously, well margins. logo activate unlocked we with enormous fan QX remains both number an is to talked and brand, Increasing Our XX.X% educating priority priority, and carries to partnership through lower of was the our against on the MLB leveraging traffic million will seasons trajectory.As lower against
rates strong remain conversion online Our at XX.X%.
from go for bring their of journey approximately account awareness showcasing significant XX% to to subscribers lifetime our subscribers, representing we ecosystem, consumer value. into purchase, becoming Our through ultimately people they revenues, when that
lower food retail QX a our prioritizing working growing channel, team mass was outperforming the year-over-year, We on X.X% on sales experience to have improving and store web cross-functional total down are user our which the category, were traffic the site.In drug XX.X%.
while the a volume overall retail strength. retail the the doors, of FDM, in channel brand and we our number number we speaks number share doors held to one dollar we As a for This saw decrease increased the result, In category. in XX.X% of position.
the XX.X% X% the XX%. on addition, channel. quarter hold natural And spend category saw to down want in channel we lower down In up a QX top in natural was the we last was the XX the the our which interesting. In while year-over-year, SKUs sales four SPM, category What of ARP minute XX.X%. were channel. again was was I outperforming the in
the Charlotte's on with and doors also the carried, shelf reducing grew rate.However, while are formats quarter SKUs taking category and of existing the number Web CBD, selling and tinctures. more two total within we doors First, retailers about and times facings and reducing the customers gummies are principally
Net tinctures of the number higher significant of impacted. than in the number while gummies of the our For negatively category. grew carrying ahead revenues mix us, were doors despite quarter penetration our slightly category, the doors the given incremental carrying declined the
for category the the That velocities. our opportunity highest of grab longer term for bodes an leadership Given well the in shelf. with Charlotte's share Web to and incremental
customer expect the and decline We for as tinctures.Moving well and our further to $X addition of impact market debenture a recreate gummies as other year-over-year, of share revenues gummies SG&A, the rate the MLB and to when first soon quarter with from fall. gain despite eclipses positively growth receptivity amortization the fee pending SG&A was completed rights particularly to convertible XX% launch we VAT lower million noncash last the amortization expense formats,
expense for Going the year quarter the to to be asset, valuable each our reflecting will XXXX include expect additional an we MLB SG&A amortization in the XXXX. three expense, SG&A MLB forward year Notwithstanding to comparable partnership. this full of related
Excluding million, these approximately which in XX% decrease is a our year-over-year. XX.X were items, amortization SG&A than expenses QX more of
first botanical is and Xth, hemp which formation the the party Our year, quarter, property, clinical structure the proprietary wanted to to earlier competitive Web DeFloria also On material the each AJNA studies significantly bulk into is million data. entirely With with to AJNA. and managed set license our BAT regulatory a of and we provisioning, the versus BioSciences drug. cash our moving we AJNA level.Net of million reduces fee BAT in the bit rights of attributable in environment. benefits to last little of the risk the in services, an for consumer existing BAT a of operating fund is was phase Charlotte's and expertise, Web. to reduces our by at financial rationale intellectual $XX BAT more X this manageable and our such collaboration current other with being contributing of Devinsky.Lastly, is certain is parties Web contributing. a contributing MLB. forward, is reduction a and against $XX and operations position discussed are project million the initial advantage use for the increase announced with contributing which QX I IND capital and end the the with to million pursue cash payment cash stable position a expenses XXXX clinical X.X Jac quarterly give Financially, Charlotte's funding which shareholders. for third the insight used the and as laboratory permitting burn fully from X.X potential Orrin Charlotte's Dr. the AJNA April collaboration including
will we the the call However, turn maintain Stanley. co-founder funding though in future to obligated.I COO, rounds, participate to now not opportunity and Jared over